Innovation Office

Since 2018, IDiBE has had an Innovation Office, funded by the Valencian Innovation Agency – IVACE+I and the European Union through FEDER funds (INNTAL11/19/011; INNTAL1/2021/11; INNTA1/2023/17). In 2022, we secured funding to convert it into a Scientific Unit for Business Innovation (INNVA2/2022/8), which has enabled us to foster collaborations with technology centers (such as AINIA, INESCOP, and AITEX) for the development of some of our main research lines. This funding was renewed in 2024 through project INNVA2/2024/3. Thanks to these projects, we have two full-time staff members dedicated to promoting knowledge transfer to the productive sector.

But the transfer of the IDiBE starts much earlier. In its two decades of history, many projects with companies have been developed, more than 35 patent applications have been filed, most of which have been licensed, and 11 spin-offs have been founded based on the developed technologies at the institute.

Our research groups are open to collaborate with innovative companies to develop and transfer new knowledge. 

Do you have a need in your biotechnology company? With IDiBE, innovation is at your fingertips.

Patent portfolio:

P202430551 – Compounds Identified as CDK4 Inhibitors for use as drugs
P202330781 – 5-fluorouracil as an antiviral agent against viruses of the family Coronaviridae
EP2138202525.1 – Treatment of NRF2-related disease
P202131183 – Persimmon dietary fibre for use with beneficial micro-organisms
P202030369 – Packaging for nutritional beverages
P201831154 – Myticin Peptide and its Use in Cell Regeneration
P201630052 – TRPM8 receptor agonist compounds and their applications (under exploitation)

Contact: